Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy

Table 3 Significance of the prognostic predictors in the univariate survival analysis

Parameters	No. of patients	Survival rate (%)		p
		2-yr	4-yr
Age (years)				0.795
>60	554	68	39
≤ 60	232	70	37
Gender				0.713
Male	576	69	42
Female	210	71	29
HBsAg				0.589
Positive	393	68	42
Negative	393	70	34
Ascites				<0.001
Yes	101	50	11
No	685	72	42
Performance status				<0.001
ECOG 0	590	75	45
ECOG 1 or higher	196	51	10
Vascular invasion				<0.001
Yes	87	35	22
No	699	72	41
AFP (ng/mL)				<0.001
>100	253	58	33
<100	533	74	42
MELD score				0.04
>10	234	62	36
<10	552	72	40
CTP score				<0.001
5	451	75	50
6 or higher	335	60	25
ALT (IU/L)				0.934
>40	499	70	38
≤ 40	287	67	40
AST (IU/L)				0.001
>40	551	65	31
≤ 40	235	77	52
Total tumor volume (cm³)				<0.001
<10	297	80	48
10-50	226	74	47
50-200	121	56	25
200-500	57	54	-
>500	85	34	10

ISSN: 1471-230X